Objectives: The objective of this study was to define metabolic normality and to investigate the cardiometabolic profile of metabolically normal obese. Design: Cross-sectional study conducted at 21 research centers in Europe. Subjects: Normal body weight (nbw, n ¼ 382) and overweight or obese (ow/ob, n ¼ 185) subjects free from metabolic syndrome and with normal glucose tolerance, were selected among the Relationship between Insulin Sensitivity and Cardiovascular Disease study participants. Main outcome measures: Insulin sensitivity was assessed by the clamp technique. On the basis of quartiles in nbw subjects, the limits of normal insulin sensitivity and of normal fasting insulinemia were established. Subjects with normal insulin sensitivity and fasting insulin were defined as metabolically normal. Results: Among ow/ob subjects, 11% were metabolically normal vs 37% among nbw, Po0.0001. Ow/ob subjects showed increased fasting insulin (P ¼ 0.0009), low-density lipoprotein cholesterol (LDL-cholesterol) (P ¼ 0.004), systolic (P ¼ 0.0007) and diastolic (P ¼ 0.001) blood pressure, as compared with nbw. When evaluating the contribution of body mass index (BMI), hyperinsulinemia and insulin resistance, BMI showed an isolated effect on high-density lipoprotein (P ¼ 0.007), high-sensitivity C-reactive protein (Po0.0001), systolic (P ¼ 0.002) and diastolic (P ¼ 0.008) blood pressures. BMI shared its influence with insulinemia on total cholesterol (P ¼ 0.04 and 0.003, respectively), LDL-cholesterol (P ¼ 0.003 and 0.006, respectively) and triglycerides (P ¼ 0.02 and 0.001, respectively). Conclusion: In obese subjects, fasting insulin should be taken into account in the definition of metabolic normality. Even when metabolically normal, obese subjects could be at increased risk for cardiometabolic diseases. Increased BMI, alone or with fasting insulin, is the major responsible for the less favorable cardio-metabolic profile.
Introduction
Obesity (ob) and overweight (ow), as defined by the body mass index (BMI) value, are associated to a higher incidence of diabetes and cardiovascular diseases (CVD). 1, 2 More recently, however, the concept that an increased fat mass is 'per se' a risk factor for metabolic and CVD has been brought into question. For instance, it has been demonstrated that, within a USA population, 32% of the phenotypically obese subjects are metabolically normal, whereas 23.5% of the subjects with a BMI in the normal range (that is, o25 kg m À2 ) exhibit clustering of cardiometabolic abnormalities. 3 Several other studies report the presence, among adult 4, 5 and young 6 obese population, of metabolically normal subjects. A difficulty, when examining these studies, is represented by the definition of metabolic normality. In fact, some authors have selected, as criterion of normality, the presence of 0 or 1 of the ATP III parameters for the metabolic syndrome, 7 whereas other have based their definition on insulin sensitivity. In turn, insulin sensitivity has been estimated either on the base of an oral glucose tolerance test and homeostasis model assessment index, 8 or using a literature-reported value of glucose uptake, measured by an euglycemic clamp. 9 Insulin resistance, which is strongly associated to obesity, is a well-defined risk factor for diabetes and has also been proposed to underlie the metabolic disorders leading to an increased risk for CVD. 10 Therefore, it seems sound to take into account insulin sensitivity together with lipid profile for the evaluation of metabolic normality in obese subjects. On the other hand, consistent reports indicate that fasting hyperinsulinemia and insulin resistance are not necessarily associated in the same individual and may independently contribute to different disorders leading to an increased risk for metabolic and CVD. 11, 12 Insulin resistance and fasting hyperinsulinemia should therefore be separately evaluated. Up today, a normal range of insulin-mediated glucose uptake and of fasting insulinemia are not defined. For this reason, the classification according to quartiles within a given study group is currently adopted. 12 In our study, we have investigated the roles of BMI, insulin sensitivity and fasting insulin on several cardiometabolic parameters in normal body weight (nbw) and in overweight or obese (ow/ob) subjects free from metabolic syndrome, according to the International Diabetes Federation (IDF) criteria, 13 and with a normal glucose tolerance.
In our study population, glucose uptake was evaluated during a euglycemic-hyperinsulinemic clamp test. Common and internal carotid intima-media thickness were used as an indicator of early-stage atherosclerosis. 14 
Subjects and methods

Study group
The study population was constituted by the Relationship between Insulin Sensitivity and Cardiovascular Disease (RISC) study cohort. The rationale and design of the RISC study has been previously published. 15 In brief, participants of an European ancestry were recruited from the local population at 21 centers in 14 European countries, according to the following inclusion criteria: either of the sex, age between 30 and 60 years and clinically healthy. Exclusion criteria were the presence of chronic diseases, overt CVD, carotid stenosis 440%, and treatment for hypertension, diabetes and dyslipidemia. Moreover, after screening, subjects only (n ¼ 1227, 619 nbw and 608 ow/ob) with blood pressure (o140/o90 mm Hg), plasma cholesterol (o7.8 mmol l
À1
), triglycerides (TG) (o4.6 mmol l À1 ), and fasting and 2-h glucose (o7.0 and 11.1 mmol l
, respectively) were enrolled. Among this cohort, we selected subjects free from metabolic syndrome, according to the IDF definition, 13 as well as with a normal glucose tolerance. This selection procedure provided 567 subjects (389 women and 178 men) with fasting glucose o5.6 mmol l
, fasting TG o1.7 mmol l
, high-density lipoprotein (HDL) cholesterol o1.03 and o1.29 mmol l À1 , respectively, in men and women, and blood pressure o130/ 85 mm Hg. As the large majority (67.4% in our ow/ob population) of ow and/or ob subjects have a waist girt larger than 94/80 cm, waist circumference was not taken into account. Among the nbw subjects, 15.5% showed a waist circumference 494/80 cm. This selection, therefore, provided subjects with 0 or 1 risk factors of metabolic syndrome, according to the IDF definition. Finally, subjects only with 2-h plasma glucose o7.8 mmol l
, after an oral glucose load, were included. Subjects were classified according to their BMI (that is, body weight/height 2 ) as nbw (that is, BMIo25 kg m À2 , n ¼ 382) or ow/ob (that is, BMIX25 kg m
À2
, n ¼ 185). The study protocol was approved by the local Ethical Committee. Participants were informed about the aims of the study, and gave their written consent.
Insulin sensitivity
Insulin sensitivity was evaluated by an euglycemichyperinsulinemic clamp. 9 Insulin was continuously infused at a rate of 240 pmol Á min À1 Á m
À2
, whereas a glucose solution (20%) was infused at variable rates to maintain a constant plasma glucose concentration between 4.5 and 5.5 mmol l
À1
. Plasma glucose was measured at 5-10 min intervals to ensure it remained within the target glucose concentration. The steadystate period (for calculation of insulin sensitivity) was between 80 and 120 min. Glucose uptake, measured during the steadystate period, was expressed in mmol per kg fat-free mass per min per pmol insulin (mmol per kg FFM per min per pmol ins). Fat-free mass was measured by TANITA bioimpedance balance (Tanita International Division, Yiewsley, Middlessex, UK).
Definition of limits for insulin resistance and hyperinsulinemia
As demonstrated in a previous 16 analysis and confirmed by our results (Table 1) , women and men displayed a significantly different insulin sensitivity. Quartiles of glucose uptake were therefore established separately in nbw women and men: subjects in the first quartile of glucose uptake were considered as insulin resistant. The cutoff values so established were o130 mmol per kg FFM per min per pmol ins for women and o107 mmol per kg FFM per min per pmol ins for men. The ow/ob subjects were than classified as insulin sensitive or resistant based on these criteria. Quartiles of fasting insulinemia were established in nbw women and men taken together, as this parameter was not influenced by sex (Table 1) . Subjects in the fourth quartile of fasting insulin (427 pmol l À1 ) were considered as hyperinsulinemic and ow/ob subjects were classified accordingly.
Carotid artery ultrasound imaging and blood pressure measurements Carotid artery intima-media imaging followed a validated protocol. 17 Longitudinal B-mode image was taken of the right and left common carotid arteries (CCAs) and internal carotid artery (ICA) from the anterior, lateral and posterior 
Assessment of physical activity
Physical activity was measured objectively by a small singleaxis accelerometer (Actigraph, AM7164-2.2; Computer Science and Applications, Pensacola, FL, USA). 19, 20 The acceleration signal was digitized with 10 samples per second, registered as counts counted over 1-min intervals. The accelerometer was worn for up to 8 days on a belt in the small of the back, from waking to bedtime, except during water-based activities. We analyzed participants with at least 3 days of data, including days when the device was worn for more than 10 h; we assumed it was not worn if there were 60 consecutive minutes with no counts. Data were checked for spurious recording: high counts 20 000 counts per min or repeated counts. 21 Daily physical activity was calculated as an average number of counts per minute when accelerometer was worn.
Statistical analysis
The differences in percent prevalence of metabolic normality were evaluated by w 2 test (Figure 1) . The values presented in tables are expressed as means±s.d. Because of their nonnormal distributions, values were statistically evaluated after log transformation. Factorial analysis of variance was used to evaluate the effects of sex and BMI ( Table 1 ). The influences Diastolic BP (mm Hg) 69 ± 7 7 3 ± 7 7 3 ± 7 7 3 ± 6 0.0001 0.0007 Heart rate (b.p.m.) 69 ± 11 70 ± 10 63 ± 10 65 ± 9 n s o0.0001 Figure 1 Percent incidence of normal glucose tolerance and absence of any metabolic syndrome-related alteration (middle panel) and of metabolic normality (lower panel) in normal body weight (nbw) and overweight/obese subjects (ow/ob) among the RISC study population. ***Po0.0001.
Obesity and cardiometabolic risk Z Pataky et al of BMI, fasting insulin and insulin sensitivity on various measured parameters, adjusted for age, sex and physical activity were first investigated separately (Model 1, Table 2 ) and then all together (Model 2, Table 2 ) by multiple regression analysis. For these analyses, both BMI and fasting insulin were used as categorical variables.
Results
Prevalence of metabolic normality
As illustrated by Figure 1 , among the clinically healthy RISC population (n ¼ 1227, 619 nbw and 608 ow/ob), 62% of nbw (that is, 382 subjects) and 37% of ow/ob (that is, 185 subjects) had a normal glucose tolerance and did not show any criterion of metabolic syndrome, according to the IDF criteria, 13 with the exception of waist circumference.
The percent prevalence was significantly different between the two groups (w 2 P-value o0.0001).
The limits for fasting hyperinsulinemia and for insulin resistance were determined as described in the Subjects and methods section. The absence of any metabolic syndrome criteria, a normal glucose tolerance together with normal insulin sensitivity and normal fasting insulin were observed in 37% of the overall nbw population (that is, 227 out of 619 nbw subjects) and in 11% of ow/ob overall group (that is, 65 out of 608 ow/ob subjects, w 2 P-value o0.0001).
Role of BMI and sex in metabolic syndrome-free subjects with normal glucose tolerance Table 1 illustrates the anthropometric and cardiometabolic characteristics of the population free from metabolic syndrome and with normal glucose tolerance, classified according to sex and BMI. Overweight/obese groups were slightly older than nbw controls (P ¼ 0.003). Higher levels of fasting glucose were significantly associated to ow/ob BMI (P ¼ 0.006) and to male sex (Po0.0001). On the contrary, glucose uptake was lower in ow/ob (Po0.0001) and in men (P ¼ 0.0005). Fasting insulin, (Po0.0001), total cholesterol (P ¼ 0.002) and highsensitivity C-reactive protein levels (Po0.0001) were higher in ow/ob of both the sexes. In addition to the wellestablished sex-linked difference, HDL was decreased in ow/ob categories (Po0.0001).
The Ow/ob BMI and male sex showed significant associations with increased LDL-cholesterol (Po0.0001 for both), TG (P ¼ 0.0003 for both), systolic blood pressure (Po0.0001 for both), diastolic blood pressure (P ¼ 0.0001 for BMI and P ¼ 0.0007 for sex), common carotid artery intima-media thickness (P ¼ 0.002 for BMI and Po0.0001 for sex).
Heart rate was higher in women (Po0.0001). Internal carotid artery intima-media thickness was influenced only by sex (P ¼ 0.0002). Ow/ob as well as women were less active when compared with their counterparts, respectively, (P ¼ 0.03 for BMI and P ¼ 0.002 for sex).
Role of BMI and sex in metabolically normal subjects Table 2 reports the anthropometric and cardiometabolic characteristics of the subjects who, among the population free from metabolic syndrome and with normal glucose tolerance, also showed normal values of fasting insulin and of glucose uptake.
The BMI subgroups did not differ in terms of age. As compared with nbw, ow/ob subjects showed increased levels Obesity and cardiometabolic risk Z Pataky et al of fasting insulin (P ¼ 0.0009) and a comparable glucose uptake that was only influenced by sex (P ¼ 0.001). Total cholesterol (P ¼ 0.02) was higher in ow/ob of both sexes. The Ow/ob BMI and male sex were linked to an increased LDL-cholesterol (P ¼ 0.004 for BMI and P ¼ 0.0001 for sex), TG (Po0.04 for BMI and Po0.0001 for sex), systolic blood pressure (P ¼ 0.0007 for BMI and Po0.0001 for sex), diastolic blood pressure (P ¼ 0.001 for BMI and P ¼ 0.008 for sex). HDL-cholesterol, heart rate, common carotid artery and internal carotid artery intima-media thickness were influenced only by sex (Po0.0001 for all).
Role of BMI, insulin sensitivity and fasting insulinemia
The effect of BMI, insulin sensitivity and fasting insulin were analyzed by multiple regression analysis, after adjustment for age, sex and physical activity. This analysis was, therefore, performed only in subjects in whom physical activity was assessed (n ¼ 355).
As illustrated in Table 3 (Model 1), when analyzed alone, BMI was significantly linked to the majority of the cardiometabolic parameters, except heart rate and common carotid artery intima-media thickness. Insulin sensitivity was associated only with waist circumference, whereas fasting insulin was linked to waist circumference, fasting glucose, total and LDL-cholesterol, TG and heart rate.
When analyzed together with insulin sensitivity and fasting insulin (Table 3 , Model 2 and Figure 2 ), BMI kept a significant, isolated effect on HDL-cholesterol (P ¼ 0.007), systolic (P ¼ 0.002) and diastolic (P ¼ 0.008) blood pressure and high-sensitivity C-reactive protein (Po0.0001). BMI shared an influence on total and LDL-cholesterol and TG with fasting insulin and on waist circumference with both fasting insulin and insulin sensitivity.
Plasma glucose level was influenced by fasting insulin and insulin sensitivity. Fasting insulin showed an isolated effect on heart rate (Po0.0001).
Discussion
As a first result (Table 1) , our data show that, even when free from metabolic syndrome and with normal glucose tolerance, ow/ob subjects have a less favorable cardiometabolic profile, characterized by a higher total and LDL-cholesterol value, lower HDL, increased values of high-sensitivity C-reactive protein and blood pressure, as well as thicker intima media of common carotid segment. This suggests a potentially higher susceptibility to CVD.
In addition, these subjects show a reduced glucose uptake and elevated levels of fasting insulin ( Table 1 ), demonstrating that metabolic syndrome-free obese yet are at higher risk for diabetes, even when presenting a normal glucose tolerance.
Finally, this last result underlines the fact that the definition of metabolic normality should take into Table 3 Relationships between BMI, insulin sensitivity and fasting insulin and various cardiometabolic parameters measured in metabolic syndrome-free and glucose-tolerant normal body weight and overweight/obese subjects 
P-value
Coef.
(95% CI)
Glucose (mmol l Abbreviations: BMI, body mass index; BP, blood pressure; CCA IMT, common carotid artery intima-media thickness; CI, confidence interval; Coef., coefficient; hs-CRP, high-sensitivity C-reactive protein; FFM, fat-free mass; HDL-chol, high-density lipoprotein cholesterol; ICA IMT, internal carotid artery intima-media thickness; LDL-chol, low-density lipoprotein cholesterol; ns, not significant. BMI, fasting insulin sensitivity and insulin were analyzed, as independent variables, for their relationships with various cardio-metabolic parameters adjusted for age, sex and physical activity. The independent variables were tested separately in Model 1 and taken together in Model 2.
Obesity and cardiometabolic risk Z Pataky et al account measurements of insulin sensitivity and fasting insulin levels. Among the overall RISC ow/ob population, only 65 (that is, 11%) had a normal glucose tolerance, no metabolic syndrome, as well as normal insulin sensitivity and fasting insulinemia, thus fitting the definition of metabolic normality. Of note, the fact that among nbw subjects also, the prevalence of metabolic normality is quite low (that is, 37%). This could be because of several reasons. First, among the various definitions of the metabolic syndrome, the one proposed by the IDF has rather restrictive threshold values; 22 second, subjects with impaired glucose tolerance were not included. Finally, we took into account both fasting insulinemia and insulin sensitivity that increases the degree of severity for the selection. The relatively small number of selected subjects could also have reduced the power of the statistical analysis and, therefore, explain the less pronounced association between BMI and the various other cardiometabolic parameters ( Table 2) .
The prevalence of metabolic normality among obese subjects is widely variable throughout the studies. For instance, Kuk et al. 23 report that only 6% of obese population was insulin sensitive and metabolic syndrome free. In this study, a sample of 6011 obese from a general population was investigated, without any exclusion for subjects showing an overt pathology: this could explain the lower incidence found by these authors. On the other hand, Wildman et al. and Iacobellis et al. 24 found an prevalence of 31 and 27.5%, respectively, of metabolically healthy obese subjects, among general populations. The slight differences in the parameters of normality selected (ATP III vs IDF criteria) together with insulin-sensitivity assessment (homeostasis model assessment index vs euglycemic-hyperinsulinemic clamp) could, at least in part, explain the notable difference in the prevalence of metabolic normality found in our and theses studies. Among our study group, 67.4% of ow/ob showed a waist 494/80 cm. For this reason, waist was not taken into account as an exclusion criteria. A similar approach has been adopted by several other authors who investigated metabolic normality in obese subjects. 3, 24 Furthermore, a recent study 25 has clearly shown that an enlarged waist, in absence of additional risk factors, is not associated to an increased risk CVD mortality. Nevertheless, it is possible that a larger depot of visceral fat contributes to the observed differences between the two BMI classes. To discriminate the contribution of the fat mass in general vs one of the visceral fat, subgroups of nbw subjects, with altered waist circumference, should be used as a comparison group. The cohort of our nbw subjects is not large enough to make this analysis, as only 15.5% of the nbw showed a waist 494/80 cm. Even when taking into account insulin sensitivity and fasting insulinemia as criteria of metabolic normality, ow/ob keep their less favorable cardiometabolic profile in comparison with nbw, as indicated by plasma lipids and blood pressure values (Table 2 ).
In addition, multiple regression analysis (Table 3 and Figure 2 ), indicates that BMI, alone or in combination with hyperinsulinemia, exerts a significant influence on the majority of the measured cardiometabolic parameters. Thus, the presence of ow and/or ob not only is per se a risk factor for reduced insulin sensitivity and hyperinsulinemia (Tables  1 and 2 ) but also for impaired cardiovascular parameters. Of note, we observed that fasting insulin is significantly associated with both total and LDL-cholesterol. In a previous study, Bonora et al.
11 demonstrated an independent contribution of insulin sensitivity and fasting insulin levels to TG and HDL-cholesterol levels; here, we show that insulinemia also affects other lipid parameters. On the other hand, we could not detect any significant association between insulin sensitivity and plasma lipids. In the majority of the cases, hyperinsulinemia compensates insulin resistance, in the early phase of impaired insulin action. It is possible that our study population was in an early phase of insulin resistance, that is, when the effects of hyperinsulinemia are already present, whereas those of insulin resistance are not yet detectable. Working on the overall RISC population, Ferrannini et al., 16 demonstrated that BMI, waist circumference, insulin sensitivity and insulinemia are the main factors influencing the cardiovascular risk parameters, but no one seemed to be the driving force of the cluster. On the contrary, our data indicate the BMI as the major factor in influencing the cardiometabolic risk parameters. This apparent contradiction could be explained by the differences in the selected study population.
In fact, the analysis carried out by Ferrannini was about the overall RISC population, whereas we investigated only glucose tolerant, metabolic syndrome-free subjects (that is, 62% of the Figure 2 Role of BMI, insulin sensitivity and fasting insulinemia in nbw and ow/ob subjects free from metabolic syndrome and with a normal glucose tolerance.
Fasting insulin
Obesity and cardiometabolic risk Z Pataky et al nbw and 37% of the ow/ob individuals participating in the RISC study, Figure 1 ). Our results, therefore, only apply on the cohort of subjects who, by definition, do not show any metabolic feature commonly associated to obesity.
It could be possible that, when hyperinsulinemia and, particularly, insulin resistance are of moderate degree (as it is the case in our subgroups), they do not have a major role in impairing the cardiometabolic profile of ow/ob subjects. However, the duration and/or degradation of insulin resistance and/or fasting insulin levels could progressively enhance their impact on the cardiometabolic parameters.
Although not confirmed by longitudinal observations, our results suggest that increased BMI initiates the sequence of events that link obesity to enhanced cardiometabolic risk.
Several questions remain to be answered to support this hypothesis: for instance, whether a progressive degradation does necessarily occur in any ow/ob individuals. Second, which is the critical degree that insulin resistance has to reach, to relevantly influence the cardiometabolic risk factors? Finally, is increased BMI alone enough to induce a progressive degradation of insulin resistance and/or hyperinsulinemia or the presence of other factors such as age, lifestyle and genetic background are needed?
Our results show differences in physical activity between nbw and ow/ob subjects, thus confirming the well-known link between excess body weight and sedentarity. 26 Furthermore, a previous RISC study, 27 clearly demonstrated the influence of physical activity on insulin sensitivity. For this reason, in our study, the influence of BMI, hyperinsulinemia and insulin resistance were analyzed after adjustment for physical activity, in addition to age and sex. In a recent paper, Messier et al. 28 underline the necessity of a consensus to standardize the definition of metabolic normality, in obese subjects. We suggest that such a definition should be based on an well-established fasting lipid and glucose values, but should also consider fasting insulinemia. This is in keeping with the results of a recent paper from our group demonstrating that fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance. 12 In conclusion, excess body weight, alone or associated to fasting hyperinsulinemia, is the major contributor to the impaired, yet normal, cardiometabolic profile of moderately obese, metabolically normal subjects, in whom insulin resistance have only a marginal role.
